盐酸多西环素注射液在猪体内残留消除规律研究

为研究自制盐酸多西环素注射液在猪体内的残留消除规律,以10 mg/kg剂量给健康猪肌内注射盐酸多西环素注射液,每日1次给药,连续三次。在最后一次给药后7、14、21、28和35 d时间点采集肌肉、肝脏、肾脏、脂肪和注射部位肌肉,用UPLC-MS/MS法测定组织中多西环素残留量。结果表明,给药35 d后,肌肉、肝脏、肾脏、脂肪和注射部位肌肉中的多西环素残留量分别为18、24、69、10、59μg/kg,均低于最高残留限量。用WT1.4软件计算休药期,盐酸多西环素注射液在猪肌肉、肝脏、肾脏、脂肪和注射部位肌肉中的休药期分别为33.9、23.8、24.8、0和36.9 d,为保证兽药安全使用、消费者身体健康与食品安全,建议盐酸多西环素注射液在猪的休药期为42 d。     

盐酸多西环素在猪体内的药物动力学及其残留

试验建立了反相高效液相色谱(RT-HPLC)法测定盐酸多西环素的浓度,探讨了盐酸多西环素在猪体内的药物动力学和残留特征。结果表明,盐酸多西环素以2.5mg/kg单剂量肌内注射给猪(n=6),药物动力学模型符合有吸收一室模型,药物动力学参数:吸收半衰期(t1/2ka)、消除半衰期(t1/2ke)为(0.400±0.312)h、(9.530±0.956)h,药时曲线下面积(AUC)为(44.414±4.123)mg·h·L-1,最大血药浓度(Cmax)为(2.811±0.136)mg/L,达峰时间(Tp)为(1.910±0.213)h。另外,以相同剂量肌内注射给猪(n=6),每天1次,连续给药4d后,在不同时间测定盐酸多西环素在猪的肌肉、肝脏、肾脏、皮肤和脂肪中的残留量。在给药后16d,盐酸多西环素在各组织均能检测到,且残留均低于残留限量。盐酸多西环素注射液在猪体内消除缓慢,残留期较长,建议休药期不低于16d。     

盐酸多西环素片在猪体内的残留消除规律研究

（目的）研究盐酸多西环素片按说明书给药后在猪体内的残留消除规律并确定休药期。（方法）将多西环素片以5 mg/kg体重口服给药，间隔24 h，连续给药5次。最后一次给药之后分别在第0日（12 h）、1日、3日、6日和8日时间点采集猪的肌肉、肝脏、肾脏和脂肪，采用建立并验证的HPLC-VWD法测定猪不同组织中多西环素的含量。（结果）方法学考察结果表明，在0.05-5 μg/mL添加范围内的线性方程和相关系数为Y=0.044x-0.414，R2=0.999。不同组织中的盐酸多西环素的平均回收率在60.32%~116.80%。（结论）为保证兽药使用安全、食品安全与人民健康，建议按照休药期计算结果确定盐酸多西环素片在猪体内的休药期为7日。     

土拉霉素在猪体内残留消除规律的研究

本研究旨在分析土拉霉素在猪体内的残留消除规律并为制定休药期提供依据。采用猪颈部一次性肌内注射土拉霉素注射液,注射剂量为2.5mg.kg-1体质量,分别在给药后第0.5,5,12,18,25,36,48天,各宰杀5头取样。样品经乙腈提取,正己烷脱脂,C18固相萃取柱(SPE)净化后用高效液相色谱—串联质谱仪分析。结果显示,给药后第0.5天注射部位药物浓度最高,第36天所有组织的药物浓度均低于最高残留限量(MRL)。用WinNonlin软件分析各组织中的消除动力学参数,消除快慢依次为注射部位,肝脏,皮脂,肌肉,肺脏和肾脏,其消除半衰期(t1/2β)分别为117.06,193.14,197.60,207.64,228.99和232.61h。肺脏的药时曲线下面积(AUC)为1 220.59μg.h.g-1仅次于注射部位及肾脏,显著高于肌肉,肝脏及皮脂。由于肾脏为代谢器官,因此可确定肺脏为土拉霉素作用的靶部位。根据欧美等国家对土拉霉素制定的最高残留限量,计算得注射部位的休药期最长,为33d。结果提示土拉霉素注射液吸收迅速,体内分布广,作用时间长。建议休药期为33d。     

盐酸多西环素片在羔羊体内残留消除规律及休药期分析

旨在确定盐酸多西环素片按照给药说明给药后在羔羊体内的残留消除规律及休药期。将盐酸多西环素片根据体重以5 mg·kg^-1内服给药，间隔24 h，连续给药5次。在最后1次给药后，分别在第0（12小时）、1、2、3、5、7和9天时间点采集羔羊脂肪、肌肉、肝和肾，采用建立并验证的HPLC-VWD方法测定组织中多西环素的含量。结果显示：方法学考察结果表明，在50~5 000 ng·mL^-1添加的线性方程和相关系数为y=0.044x-0.414，R²=0.999。试验结果表明，多西环素在羔羊组织中代谢快速，最后1次给药后第9天，在肌肉、肝、肾和脂肪中均未检测到多西环素。本试验以5 mg·kg^-1体重内服给予羔羊盐酸多西环素片后，根据欧洲药品评估机构法规《EMEA/CVMP/036/95》，建议盐酸多西环素片在羔羊组织中的休药期为2 d。     

恩诺沙星注射液在猪体内的残留消除研究

为研究恩诺沙星在猪体内的残留消除规律,验证休药期,以2.5 mg/kg体重肌内注射10%恩诺沙星注射液,每日2次,连续3 d。在最后一次给药后0、3、5、7、10 d时间点,采集肌肉、肝脏、肾脏、脂肪和注射部位肌肉,HPLC法测定组织中的恩诺沙星及其代谢物环丙沙星的残留量,并用WT1.4软件计算休药期。结果显示,恩诺沙星在猪肌肉、肝脏、肾脏、脂肪和注射部位肌肉的休药期分别是5.6、13.4、8.2、3.0、5.5 d。为保证兽药使用安全、消费者健康和食品安全,推荐恩诺沙星注射液在猪的休药期为14 d。     

脱氢醋酸钠在猪组织中的残留研究

旨在研究脱氢醋酸钠作为饲料防霉剂应用后在猪组织中的残留消除。选用33只健康杜长大三元杂交猪,200 mg/kg脱氢醋酸钠拌料饲喂1个月。分别于停药1～21 d的不同时间取肌肉、肝脏、肾脏和脂肪组织, HPLC法测定脱氢醋酸钠含量。结果表明,脱氢醋酸钠在猪肾脏和肝脏组织中的残留水平较高,肌肉次之,脂肪中最少。休药1 d时,猪肾脏、肝脏、肌肉和脂肪中的平均残留量分别为1.12 mg/kg、1.06 mg/kg、0.59 mg/kg和0.21 mg/kg;脱氢乙酸钠在组织中的含量低于定量限0.2 mg/kg水平所需要的休药时间分别为:肌肉6 d、肝脏11 d、肾脏13 d、脂肪1 d后。脱氢乙酸钠在猪不同组织中的残留消除半衰期分别为:肌肉6.7 d、肝脏7.2 d、肾脏9.1 d、脂肪5.4 d。上述结果显示,脱氢乙酸钠在猪组织中的残留消除相对较快,组织残留量均低于1.2 mg/kg。     

牛皮下注射爱普菌素的组织药代动力学试验

牛皮下单次注射爱普菌素注射剂,剂量为0.5 mg/kg,给药后在不同时间点采取肌肉、肝脏、肾脏和脂肪等组织样品检测爱普菌素残留,采用3P97软件对组织残留-停药时间数据进行分析.结果表明,注射部位、肝脏中爱普菌素残留浓度变化符合二室开放模型,肌肉、肾脏、脂肪中EPR残留浓度变化符合一室开放模型.爱普菌素经皮下注射后Tmax均小于1 d(0.17～0.76 d),Cmax范围在37.32～1453.79 ng/g之间.MRT范围在7.54～14.79 d之间,与T1/2el范围2.91～19.50 d相一致,说明药物在动物体内消除缓慢.     

盐酸沃尼妙林预混剂在猪组织中残留消除规律研究

建立了猪肝脏、肾脏、肌肉和脂肪中盐酸沃尼妙林的高效液相色谱检测方法并研究盐酸沃尼妙林预混剂在猪体内各组织中的残留消除规律。对24头健康猪以200mg/kg的剂量混饲给药21d。在停药后0、6、12、18、24、36h分别宰杀4头猪,采集各组织进行药物残留测定。方法的检测限为0.025～0.062 5μg/g,定量限为0.05～0.1μg/g,肝脏的平均回收率为75.5%～76.4%,变异系数为2.3%～3.8%;肾脏的平均回收率为75.8%～78.5%,变异系数为4.1%～6.0%;肌肉的平均回收率为79.3%～80.0%,变异系数为3.0%～4.7%;脂肪的平均回收率为76.7%～77.3%,变异系数为3.3%～5.4%。结果表明,盐酸沃尼妙林在肝脏中残留量最高,肾脏其次;肌肉和脂肪中的残留量显著低于肝脏和肾脏,停药24h时,残留量低于定量限;停药36h时残留量均低至检测限以下。盐酸沃尼妙林预混剂在猪组织中消除迅速,建议休药期为2d。     

猪肾脏等组织中盐酸莱克多巴胺的HPLC检测方法及其残留消除

本研究建立了猪肝脏、肾脏、肌肉和脂肪中盐酸莱克多巴胺的高效液相色谱检测方法。方法的检测限为1ng/g,定量限为2 ng/g,肝脏的平均回收率在73.4%～83.2%,变异系数在2.1%～6.6%;肾脏的平均回收率在73.1%～95.5%,变异系数在3.8%～4.0%;肌肉的平均回收率在80.7%～82.5%,变异系数在4.9%～9.1%;脂肪的平均回收率在73.3%～78.8%,变异系数在2.9%～6.7%。对60头健康猪以18 mg/kg的剂量混饲给药28d,停药饲喂14 d。在给药7、142、8 d和停药1、2、3、7、9、14 d分别屠宰6头猪,取各组织进行残留量测定。结果显示：肾脏中残留量最高,肝脏其次,残留量在停药期间较给药期间显著降低。其中肾脏和肝脏中的残留量分别在停药14 d、停药9 d后降至定量限以下;肌肉和脂肪中的残留量显著低于肾脏和肝脏,给药28 d时,残留基本低于定量限;停药1 d时均低至检测限以下。     

Retention of selenium in tissues of calves, lambs, and pigs after parenteral injection of a selenium-vitamin E preparation.

Four each healthy weaned calves, lambs, and pigs raised in Indiana without selenium supplementation were killed, and their tissues were fluorometrically analyzed to establish base line selenium concentrations. The following mean selenium content (in ppm, wet weight) was found in calves, lambs, and pigs, respectively: liver, 0.12, 0.16, and 0.19; renal cortex, 0.63, 0.89, and 0.70; muscle, 0.05, 0.05, and 0.06. Eight each additional healthy weaned calves, lambs, and pigs were injected with a commercial selenium-vitamin E preparation at dose levels of 0.0825, 0.055, or 0.06 mg of Se (as selenite) per kilogram of body weight, respectively. Selenium content of tissues was measured in animals killed at 1, 7, 14, and 23 days after injection. In calves, concentrations in liver and kidney rapidly increased to moderate values and then slowly decreased, with mean concentrations after 23 days still somewhat greater than base line values. Concentrations for injection site tissue also rapidly increased to moderate values, but had decreased to base line values by 23 days after injection. In lambs, selenium content of liver was moderately increased after injection, but had decreased to base line values after 14 days; kidney and injection site did not have increased selenium content after injection. In pigs, liver and kidney had moderate initial increases in concentration of selenium, but these were at base line values after 14 days, and increase did not occur at injection sites.     

Tylosin depletion from edible pig tissues

The depletion of tylosin from edible pig tissues was studied following 5 days of intramuscular (i.m.) administration of 10 mg/kg of tylosin to 16 crossbreed pigs. Animals were slaughtered at intervals after treatment and samples of muscle, kidney, liver, skin+fat, and injection site were collected and analysed by high-performance liquid chromatography (HPLC). Seven days after the completion of treatment, the concentration of tylosin in kidney, skin+fat, and at the injection site was higher than the European Union maximal residue limit (MRL) of 100 microg/kg. Tylosin residues in all tissues were below the quantification limit (50 microg/kg) at 10 and 14 days post-treatment.     

给猪注射pGRF基因质粒安全性的研究

将56头35日龄断奶DLY仔猪,随机分为4个处理,每个处理2个重复,每个重复7头猪。4个处理分别为对照组、3 mg组(第1天注射3 mg pGRF)、6 mg组(第1、45天分别注射3 mg pGRF)、9 mg组(第1天注射3 mgGRF、第45天注射6 mg pGRF)。到150 d时结束饲养试验,每个处理选择8头猪进行放血屠宰。屠宰前采试猪的全血10 mL制备血浆,分别测定血浆GH、SS和GRF的含量;屠宰后取心、肝、脾、肺和肾各一块用于制作组织切片;另取心、肝、脾、肺、肾、注射质粒部位肌肉和非注射部位肌肉各一块用于检测质粒的残留。结果表明:屠宰前各处理血浆激素的浓度没有显著差异(P>0.05),注射3 mg和6 mg使猪肝脏的器官系数显著下降(P<0.05),对其他器官和功能没有产生不良影响;注射9 mg使肝脏和肾脏产生广泛的颗粒变性。质粒的残留仅在9 mg组注射部位肌肉中能检测到。综合各项试验结果6 mg以下注射剂量的pGRF基因质粒在养猪生产上的使用是安全的。     

Application of diethylstilbestrol dipropionate in bulls. II. Residues in bile, liver, kidney, muscle tissues and application site

The second part of an experiment is described in which 20 one year old bulls were injected with diethylstilbestrol (DES) dipropionate containing preparations. Analysis of DES content was performed in several tissues, such as the injection site, diaphragm muscle, psoas muscle, liver, kidney and bile. In the injection site appreciable amounts of DES were found. Measurable amounts of DES were also found in liver and kidney until 4 weeks after injection. In bile, DES concentrations were even higher than those in urine, and were well correlated with DES concentrations in urine. Implications for screening purposes are discussed.     

Disposition kinetics of doxycycline in chickens naturally infected with Mycoplasma gallisepticum

1. The pharmacokinetic properties of doxycycline were determined in healthy chickens and chickens naturally infected with Mycoplasma gallisepticum after a single intravenous (i.v.) and oral administration of the drug at 20 mg/kg body weight. Tissue residues of the tested drug after an oral dose of 20 mg/kg given twice daily for 5 consecutive days were also estimated in diseased chickens. 2. The plasma concentrations of doxycycline following single i.v. and oral administration were higher in healthy chickens than in diseased ones. Following i.v. injection, the elimination half-life (t1/2beta), distribution half-life and mean residence time (MRT) were longer in healthy chickens than in diseased birds. The values of total body clearance (ClB) and volume of distribution (Vdss) were larger in healthy chickens than in diseased birds. 3. After single oral administration, the absorption half-life (tl/2ab) and the elimination half-life were longer in normal birds than in diseased ones. The maximum plasma concentration of the drug was higher in normal chickens than in diseased ones. 4. Following repeated oral administration, the concentration of doxycycline in all tissues except muscle was higher than the corresponding concentrations in plasma. Concentrations of doxycycline in different tissues were in the following order: kidney > liver > lung > muscle. The drug was detected in liver and kidney in substantial concentrations on d 5 post administration of the last dose whereas, on d 7, its concentration in all tissues was below the lower limit of the sensitivity of the assay method used. Because of the low sensitivity of the microbiological assay method used in this study, a safe withdrawal time for doxycycline in diseased birds could not be estimated for the meanwhile.     

Application of diethylstilbestrol dipropionate in bulls

Summary

The second part of an experiment is described in which 20 one year old bulls were injected with diethylstilbestrol (DES) dipropionate containing preparations. Analysis of DES content was performed in several tissues, such as the injection site, diaphragm muscle, psoas muscle, liver, kidney and bile. In the injection site appreciable amounts of DES were found. Measurable amounts of DES were also found in liver and kidney until 4 weeks after injection. In bile, DES concentrations were even higher than those in urine, and were well correlated with DES concentrations in urine.

Implications for screening purposes are discussed.     

The Expression Characteristics of MYNN Gene in Different Tissues and Muscles of Pig

This study was aimed to investigate the expression characteristics of myoneurin (MYNN) gene in different tissues and its developmental expression in muscles (longissimus dorsi, biceps femoris and psoas major), cerebellum, liver, pancreas, kidney, stomach, spleen and lung tissues of pigs. The expression characteristics of MYNN mRNA in 11 different tissues including heart, liver, spleen, lung, kidney, cerebellum, small intestine, pancreas, stomach, biceps femoris and fat of Large White pigs and Mashen pigs at the age of 90 days and the developmental expression patterns in muscle, cerebellum, liver, pancreas, kidney, stomach, spleen at three strages (1, 90, 180 days) of Large White pigs and Mashen pigs were studied by Real-time PCR. The results showed that MYNN was widely expressed in various tissues of pigs, and there was significant difference among the tissues(P < 0.05; P < 0.01); The expression of MYNN in muscle, liver, pancreas, cerebellum, kidney, stomach, spleen, lung tissues were significant difference at three development stages of Large White pigs and Mashen pigs(P < 0.05; P < 0.01), and also had a specific rule, which indicated that it may play an important role in these pig tissues. The expression of MYNN gene could related to the tissue, age and the genetic background of breeds. The results of this study provided a better understanding of the biological functions of pig MYNN. Further studies are required to determine its molecular mechanisms, especially in the regulation of skeletal muscle development.     

MYNN基因在猪不同组织及肌肉中的表达规律

试验旨在研究myoneurin（MYNN）基因在猪不同组织中的表达特征及其在肌肉（背最长肌、股二头肌和腰大肌）、小脑、肝脏、胰脏、肾脏、胃、脾脏、肺脏组织中的发育性表达规律。采用实时荧光定量PCR技术研究猪MYNN mRNA在90日龄大白猪和马身猪的心脏、肝脏、脾脏、肺脏、肾脏、小脑、小肠、胰脏、胃、股二头肌及脂肪共11个组织中的表达谱,以及在大白猪和马身猪1、90、180日龄3个发育阶段的肌肉、小脑、肝脏、胰脏、肾脏、胃、脾脏、肺脏组织中的发育性表达规律。结果表明,MYNN在猪的各种组织中广泛表达,且各组织间表达差异显著或极显著（P < 0.05;P < 0.01）;MYNN在大白猪和马身猪的肌肉、小脑、肝脏、胰脏、肾脏、胃、脾脏、肺脏组织中的不同发育阶段表达差异显著或极显著（P < 0.05;P < 0.01）,并具有特定规律,由此推测其可能在猪的这几种组织中发挥重要作用。MYNN基因的表达与组织、日龄及品种的遗传背景有关。本试验为研究猪MYNN基因的生物学功能提供了依据,但还需要深入的研究来探索其作用的具体机制,尤其是在骨骼肌发育中的调节机制。     

Tissue residue depletion of oxytetracycline after repeated intramuscular administration of Oxysentin 100 in sheep

The depletion profile of oxytetracycline was studied in healthy sheep after intramuscular administration of Oxysentin 100, given at a dose of 10 mg oxytetracycline per kg body weight once daily for 5 consecutive days. Five medicated sheep were slaughtered at 0, 2, 4, 6, 9 and 12 days postmedication, and injection site, muscle, fat, liver and kidney tissues were sampled and analysed using a liquid chromatographic method, which was fully validated for oxytetracycline and 4-epi-oxytetracycline. At day 0 postmedication, the concentrations of oxytetracycline marker residue (sum of oxytetracycline and 4-epi-oxytetracycline) in all tissues examined were at the mg/kg level. At day 2 postmedication, the concentrations of oxytetracycline marker residue in all injection site and kidney samples examined were higher than the corresponding maximum residue limits (MRLs) established by the European Union, while the concentrations in muscle and liver tissues of two and three out of five animals examined, respectively, were below the corresponding MRLs. At days 4 and 6 postmedication, concentrations of oxytetracycline marker residue above the MRLs were found only in the injection site, whereas at day 9 postmedication, all observations were below the corresponding MRLs.